Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > (CPH) MC $30 M /$200 M Drug got APPROVAL today=1000% RALLYYY

<< Previous

Bullboard Posts

Next >>

Comment by Thesweethearton Oct 18, 2019 9:59am

40 Views

Post# 30243471

RE:(CPH) MC $30 M /$200 M Drug got APPROVAL today=1000% RALLYYY

Save the effort! This is the wrong board! After its all said and done, no money left here!

Cannabisbiatch wrote:

CPH got trulance APPROVALLLLLLLLLL and more good news on the way ...Next Approval likely next week ..UNDISCOVERED POTENTIAL 10 BAGGERRRRRRR GEM

Cipher Pharma (CPH.T )

Market-cap $30 M // Cash $ 10 M // Profitable Company

Cipher Pharmaceuticals Receives Health Canada Approval For Trulance® (Plecanatide)..Oct. 18, 2019
https://finance.yahoo.com/news/cipher-pharmaceuticals-receives-health-canada-110000703.html

It is estimated that one in four Canadians has symptoms of constipation and an estimated 38% of Canadians report constipation within the previous 12 months.According to IQVIA the total Canadian laxative and antispasmodic market (prescription and OTC) was valued at over CDN $200 million for the 12 months ending December 2018.

Cipher acquired the Canadian rights to develop, market, distribute and sell TRULANCE® from Bausch Health Companies Inc.

Cipher anticipates several key milestones in 2019 that will continue to enhance long term value, including:

Regulatory approval for A-101 from Health Canada in Q4 2019

Top line results for MOB-015 Phase 3 study in North America expected in late Q4 2019

Partnerships for commercial and pipeline assets